Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw strong trading volume on Wednesday . 265,874 shares changed hands during trading, an increase of 699% from the previous session's volume of 33,262 shares.The stock last traded at $71.93 and had previously closed at $71.55.
Novozymes A/S Stock Performance
The company has a 50 day simple moving average of $70.68 and a 200-day simple moving average of $62.65. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.73 and a quick ratio of 1.06. The stock has a market cap of $33.42 billion, a P/E ratio of 45.16, a price-to-earnings-growth ratio of 1.36 and a beta of 0.91.
Novozymes A/S Company Profile
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Articles
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
